Adenocarcinoma of lung

disorder

SNOMED 254626006CUI C0152013

Overview

Source: MedlinePlus.gov, National Library of Medicine. Not a substitute for medical advice.

Clinical Trials

Total Trials

Recruiting

With Results

Recent Trials

Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung Cancer

NCT03199651N/ARecruiting3,584 enrolled

TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers

NCT04485013Phase 1Recruiting240 enrolled

Engagement of Veterans With Lung Cancer

NCT07219251N/ARecruiting194 enrolled

Testing the Safety of Dapagliflozin Prior to Surgery for the Treatment of Patients With Stage IA Lung Adenocarcinoma

NCT07235280EARLY_Phase 1Recruiting48 enrolled

Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer

NCT05198830Phase 2Recruiting42 enrolled

View all 7 trials on ClinicalTrials.gov

Signs & Symptoms

Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.

Alveolar cell carcinoma

HP:0006519

Lung adenocarcinoma

HP:0030078

Non-small cell lung cancer

HP:0030358

Quick Facts

SNOMED CT: 254626006
UMLS CUI: C0152013
Fully Specified Name: Adenocarcinoma of lung (disorder)
Specialists: 0
Diagnostic Biomarkers: 0
HPO Phenotypes: 3
Clinical Trials: 7

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.